<!doctype html>
<html lang="en">
<head>
  <meta charset="utf-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1" />
  <title>N‑Methyl‑Cyclazodone (NMC) • A Public Health Warning</title>
  <meta name="color-scheme" content="dark">
  <link rel="preconnect" href="https://fonts.googleapis.com">
  <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
  <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">

  <style>
    /* * XFCE (Greybird-dark) Inspired Theme 
     * This theme uses a palette of charcoal grays and a classic accent blue
     * to create a professional, focused, and clean appearance.
     */
    :root {
      /* Base dark theme inspired by XFCE/Greybird */
      --bg-0: #2e3436; /* Dark charcoal main background */
      --bg-1: #353a3c; /* Slightly lighter background */
      --bg-card: #3c4143; /* Card and element background */
      --elev-1: 0 4px 12px rgba(0,0,0,0.3), 0 1px 3px rgba(0,0,0,0.2);

      /* Text colors for high contrast and readability */
      --txt-0: #eeeeec; /* Primary text (headings) */
      --txt-1: #d3d7cf; /* Secondary text (body) */
      --muted: #babdb6; /* Muted/metadata text */

      /* Classic XFCE blue accent palette */
      --accent: #729fcf;      /* Main accent blue for links, buttons */
      --accent-hover: #8cc0ff; /* Lighter blue for hover states */
      --warning: #f57900;     /* Orange for notices */
      --warning-bg: rgba(245, 121, 0, 0.1);
      --warning-border: rgba(245, 121, 0, 0.4);
      --danger: #cc0000;      /* Red for critical danger */
      --danger-bg: rgba(204, 0, 0, 0.1);
      --danger-border: rgba(204, 0, 0, 0.4);
      --success: #8ae234;     /* Green for success tags */
      --success-bg: rgba(138, 226, 52, 0.1);
      --success-border: rgba(138, 226, 52, 0.4);

      /* Borders and UI elements */
      --bd-strong: #555753;
      --bd-soft: #4a4f51;

      /* Code, selection, and focus styles */
      --code-bg: #2a2f30;
      --sel: rgba(114, 159, 207, 0.25);
      --focus: 0 0 0 3px rgba(114, 159, 207, 0.35);

      /* Typography */
      --font-sans: 'Inter', ui-sans-serif, system-ui, -apple-system, Segoe UI, Roboto, Helvetica, Arial, "Apple Color Emoji", "Segoe UI Emoji";
      --font-mono: ui-monospace, SFMono-Regular, Menlo, Monaco, Consolas, "Liberation Mono", "Courier New", monospace;
    }

    /* Basic Reset & Body Styling */
    * { box-sizing: border-box; }
    html, body {
      margin: 0;
      padding: 0;
      background-color: var(--bg-0);
      color: var(--txt-1);
      font-family: var(--font-sans);
      line-height: 1.65;
      -webkit-font-smoothing: antialiased;
      -moz-osx-font-smoothing: grayscale;
    }

    ::selection { background: var(--sel); }

    a {
      color: var(--accent);
      text-decoration: none;
      transition: color 0.15s ease;
    }
    a:hover { 
      color: var(--accent-hover);
      text-decoration: underline; 
    }

    /* Main Content Container */
    .container {
      max-width: 850px;
      margin: 0 auto;
      padding: 80px 20px 40px;
    }

    /* Sticky Header */
    .site-header {
      position: sticky;
      top: 0;
      z-index: 50;
      backdrop-filter: saturate(120%) blur(8px);
      -webkit-backdrop-filter: saturate(120%) blur(8px);
      background: rgba(46, 52, 54, 0.8);
      border-bottom: 1px solid var(--bd-soft);
    }
    .nav {
      max-width: 850px;
      margin: 0 auto;
      padding: 12px 20px;
      display: flex;
      align-items: center;
      gap: 12px;
    }
    .dot {
      width: 10px; height: 10px; border-radius: 50%;
      background-color: var(--accent);
      box-shadow: 0 0 10px rgba(114, 159, 207, 0.5);
    }
    .brand {
      font-weight: 600;
      font-size: 1.05rem;
      color: var(--txt-0);
    }
    .tag {
      margin-left: auto;
      font-size: 0.75rem;
      font-weight: 500;
      color: var(--txt-1);
      background: var(--bg-1);
      border: 1px solid var(--bd-soft);
      padding: 4px 10px;
      border-radius: 999px;
    }

    /* Typography */
    h1 {
      margin: 0 0 8px;
      font-size: 2.25rem;
      font-weight: 800;
      letter-spacing: -0.04em;
      color: var(--txt-0);
      line-height: 1.2;
    }
    .meta {
      color: var(--muted);
      font-size: 0.9rem;
    }
    h2 {
      margin: 0 0 12px;
      font-size: 1.5rem;
      font-weight: 700;
      color: var(--txt-0);
      letter-spacing: -0.02em;
    }
    h3 {
      margin: 16px 0 8px;
      font-size: 1.1rem;
      font-weight: 600;
      color: var(--txt-0);
    }
    p { margin: 8px 0 0; }
    ul {
      margin: 8px 0 0;
      padding-left: 20px;
    }
    li { margin: 6px 0; padding-left: 4px; }
    li::marker { color: var(--accent); }

    /* Cards & Sections */
    .card {
      background: var(--bg-card);
      border: 1px solid var(--bd-soft);
      border-radius: 12px;
      box-shadow: var(--elev-1);
      padding: 24px;
      margin: 24px 0;
      transition: border-color 0.2s ease, transform 0.2s ease;
    }
    .card:hover {
      border-color: var(--bd-strong);
    }

    /* Special Notice Card */
    .notice {
      background: var(--warning-bg);
      border: 1px solid var(--warning-border);
      color: var(--txt-1);
      padding: 24px;
      border-radius: 12px;
      box-shadow: var(--elev-1);
      margin: 32px 0;
    }
    .notice h2 { color: var(--warning); }
    .notice strong { color: var(--warning); font-weight: 600; }

    /* Danger Notice Card */
    .danger {
      background: var(--danger-bg);
      border: 1px solid var(--danger-border);
      color: var(--txt-1);
      padding: 24px;
      border-radius: 12px;
      box-shadow: var(--elev-1);
      margin: 24px 0;
    }
    .danger h2 { color: var(--danger); }
    .danger strong { color: var(--danger); font-weight: 600; }


    /* Pills / Tags */
    .pill {
      display: inline-block;
      padding: 4px 12px;
      border-radius: 999px;
      font-size: 0.8rem;
      font-weight: 500;
      border: 1px solid var(--bd-soft);
      color: var(--txt-1);
      background: var(--bg-1);
    }
    .pill.warn {
      background: var(--warning-bg);
      border-color: var(--warning-border);
      color: var(--warning);
    }
    .pill.ok {
      background: var(--success-bg);
      border-color: var(--success-border);
      color: var(--success);
    }

    .kbd {
      font-family: var(--font-mono);
      background: var(--code-bg);
      border: 1px solid var(--bd-soft);
      padding: 0.2em 0.45em;
      border-radius: 6px;
      font-size: 0.9em;
      color: var(--txt-0);
    }

    /* Action Buttons */
    .actions {
      display: flex;
      flex-wrap: wrap;
      gap: 12px;
      margin-top: 16px;
    }
    .btn {
      appearance: none;
      border: 1px solid var(--bd-strong);
      background-color: var(--bg-1);
      color: var(--txt-0);
      padding: 10px 18px;
      border-radius: 8px;
      font-weight: 600;
      transition: all .15s ease;
      box-shadow: 0 1px 2px rgba(0,0,0,0.2);
      cursor: pointer;
      text-decoration: none;
      display: inline-flex;
      align-items: center;
      gap: 8px;
    }
    .btn:hover {
      transform: translateY(-2px);
      box-shadow: 0 4px 8px rgba(0,0,0,0.3);
      background-color: var(--bg-card);
      border-color: var(--muted);
      text-decoration: none;
    }
    .btn.primary {
      background-color: var(--accent);
      border-color: var(--accent);
      color: #111;
    }
    .btn.primary:hover {
      background-color: var(--accent-hover);
      border-color: var(--accent-hover);
    }

    /* Footer */
    .footer {
      margin-top: 32px;
      padding-top: 24px;
      border-top: 1px solid var(--bd-soft);
      color: var(--muted);
      font-size: 0.85rem;
    }
    .meta-grid {
      display: grid;
      grid-template-columns: auto 1fr;
      gap: 8px 16px;
      margin-bottom: 16px;
    }
    .meta-grid strong {
      color: var(--txt-1);
    }

    /* Responsive Adjustments */
    @media (max-width: 640px) {
      .container { padding-top: 72px; }
      h1 { font-size: 1.8rem; }
      h2 { font-size: 1.3rem; }
      .meta-grid { grid-template-columns: 1fr; }
    }

    /* Accessibility */
    :focus-visible { 
        outline: none; 
        box-shadow: var(--focus); 
        border-radius: 6px; 
    }
  </style>
</head>
<body>
  <header class="site-header" role="banner">
    <nav class="nav" aria-label="Primary">
      <span class="dot" aria-hidden="true"></span>
      <span class="brand">NMC Public Health Warning</span>
      <span class="tag">Harm Reduction</span>
    </nav>
  </header>

  <main class="container" role="main">
    <section aria-label="Introduction">
        <h1>N-Methyl-Cyclazodone (NMC): A Warning</h1>
        <p class="meta">
          Understanding the serious risks of this unregulated 'study drug', especially the danger of sudden liver failure.
        </p>
    </section>

    <section class="notice" aria-label="Critical safety notice">
      <h2>A Serious Warning About Your Liver</h2>
      <p>
        The most dangerous risk of using <strong>N‑Methyl‑Cyclazodone (NMC)</strong> is sudden, unpredictable, and potentially fatal liver failure. This is not a common side effect, but a rare catastrophe that can happen without warning. Because it belongs to a chemical family known for causing liver damage, this risk must be taken seriously.
      </p>
    </section>

    <section class="danger" aria-label="Critical drug interaction warning">
      <h2>Danger: Interacts With Common Medications</h2>
      <p>
        Mixing NMC with other drugs can be extremely dangerous. A documented case showed that taking NMC while on a common antidepressant (like an SSRI) led to a life-threatening overdose. The combination can cause the body to be unable to process the drug, leading to toxic levels in your system. <strong>Do not mix NMC with other medications. Examples include Bupropion which inhibits CYP2D6 for 5-6 days because of the long half life of its metabolites, Grapefruit and related foods containing CYP3 inhibitors</strong>
      </p>
    </section>

    <section class="card" aria-labelledby="exec">
      <h2 id="exec">Key Dangers at a Glance</h2>
      <ul>
        <li><strong>What it is:</strong> An unregulated stimulant, chemically related to other drugs in a family known for causing severe side effects.</li>
        <li><strong>How it's used:</strong> Often sold online as a 'research chemical' and used as a so-called 'smart drug' or for self-treating ADHD.</li>
        <li><strong>The Biggest Danger:</strong> A risk of sudden, severe, and irreversible liver failure. A related drug was banned because it caused deaths and required liver transplants.</li>
        <li><strong>Overdose Effects:</strong> A documented overdose caused life-threatening effects, including dangerous heart problems, severe muscle breakdown, and brain and nerve damage.</li>
        <li><strong>Is it legal?:</strong> It exists in a legal gray area in many places, but is illegal to sell for human use in countries like the UK.</li>
      </ul>
    </section>

    <section class="card" aria-labelledby="identifiers">
        <h2 id="identifiers">Chemical Information</h2>
        <div class="meta-grid">
            <strong>Common Names:</strong> <span>N‑Methyl‑Cyclazodone, NMC</span>
            <strong>CAS Number:</strong> <span>14461‑92‑8</span>
            <strong>Chemical Class:</strong> <span>5‑phenyl‑4‑oxazolidinone stimulant</span>
        </div>
    </section>

    <section class="card" aria-labelledby="download">
      <h2 id="download">Read the Full Scientific Report</h2>
      <p>For a deep dive into the science, including detailed case studies and chemical analysis, you can download the complete PDF report.</p>
      <div class="actions">
        <a class="btn primary" href="./N-Methyl-Cyclazodone-Human-Use-Analysis.pdf" role="button" aria-label="Download PDF">
          <svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2.5" stroke-linecap="round" stroke-linejoin="round"><path d="M21 15v4a2 2 0 0 1-2 2H5a2 2 0 0 1-2-2v-4"></path><polyline points="7 10 12 15 17 10"></polyline><line x1="12" y1="15" x2="12" y2="3"></line></svg>
          Download PDF
        </a>
        <a class="btn" href="./N-Methyl-Cyclazodone-Human-Use-Analysis.pdf" target="_blank" rel="noopener" role="button" aria-label="View PDF in browser">
          <svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" viewBox="0 0 24 24" fill="none" stroke="currentColor" stroke-width="2.5" stroke-linecap="round" stroke-linejoin="round"><path d="M1 12s4-8 11-8 11 8 11 8-4 8-11 8-11-8-11-8z"></path><circle cx="12" cy="12" r="3"></circle></svg>
          View in Browser
        </a>
      </div>
    </section>

    <footer class="footer" role="contentinfo" aria-label="Document metadata">
      <div class="meta-grid">
        <strong>Source:</strong> <span>Based on the report "N‑Methyl‑Cyclazodone: A Pharmacological and Toxicological Assessment"</span>
        <strong>Contact:</strong> <span><a href="mailto:pharmacology@catom.dev">pharmacology@catom.dev</a></span>
      </div>
      <p class="muted">
        This page is for public health awareness and harm reduction. It is not medical or legal advice. The software and associated documentation files are provided under the MIT License.
      </p>
    </footer>
  </main>
</body>
</html>
